CIK: 1604572 - Address: C/o Adamas Pharmaceuticals, Inc., 1900 Powell St., Suite 750, Emeryville, CA 94608
18 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret119039151629
S%wins67333333446346

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/20/16 17:49
4/18/16
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdS.d-66618.505-36-818D36-119-2027254-342-11-14-16
4/20/16 17:49
4/18/16
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdM.d381.055368D36-119-2027254-342-11-14-16
6/9/15 17:54
6/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdS.d-3818.952-2-701D236161076-4616400-13-9
6/9/15 17:54
6/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdM.d41.76221D236161076-4616400-13-9
5/7/15 16:52
5/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdS.d-3517.622-2-701D-12735-204-111040-6-15
5/7/15 16:52
5/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdM.d41.76221D-12735-204-111040-6-15
4/7/15 16:30
4/6/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdS.d-3517.442-2-701D-13-1-104-1-31-154-5-7
4/7/15 16:30
4/6/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdM.d41.76221D-13-1-104-1-31-154-5-7
3/9/15 17:58
3/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdS.d-3417.151-2-701D-316-1-1-3-2-1561714-8
3/9/15 17:58
3/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdM.d41.76121D-316-1-1-3-2-1561714-8
2/6/15 17:36
2/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdS.d-3416.871-2-701D661710112-1642-8
2/6/15 17:36
2/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdM.d41.76121D661710112-1642-8
1/7/15 18:39
1/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdS.d-3517.594-2-701D-3-911172-500105840
1/7/15 18:39
1/5/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdM.d41.76421D-3-911172-500105840
12/9/14 17:48
12/5/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdS.d-2814.011-2-701D-29-22-10-7-7-5-2-318164011
12/9/14 17:48
12/5/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdM.d41.76121D-29-22-10-7-7-5-2-318164011
12/3/14 20:00
12/1/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdM.d351.761201D-18-191-4-2-2-4-120203114
12/3/14 20:00
12/1/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcClure NatalieCAOSVP,ProdS.d-29014.501-20-961D-18-191-4-2-2-4-120203114

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact